March 19, 2024
by Andrii Buvailo, PhD
News
Denmark is set to create a national AI innovation centre in collaboration with NVIDIA, aiming to host one of the …
The field of AI ligand pose prediction in the protein binding pockets (aka “AI docking”) witnessed unprecedented development in the …
March 18, 2024
by Irina Bilous
Biopharma insight
Historically, the approval rate for medicines treating central nervous system (CNS) disorders was low. By 2022, the success rate for …
March 17, 2024
by Andrii Buvailo
Biopharma insight
As artificial intelligence (AI) foundation models grow increasingly capable, they become useful for applications across a wide range of economic …
March 14, 2024
by Andrii Buvailo, PhD
News
Basecamp Research announced the development of BaseFold, a new deep learning model designed to predict the 3D structures of large, …
March 14, 2024
by Andrii Buvailo
Biopharma insight
2023 has marked a remarkable year of technological advancements in drug discovery and biotechnology. Ironically, the elation from a kaleidoscope …
March 11, 2024
by Andrii Buvailo, PhD
News
Recursion (NASDAQ: RXRX), a clinical-stage TechBio company, has unveiled plans to establish a new office in London's King’s Cross area, …
March 6, 2024
by Dominika Wilczok
Biopharma insight
Recently, the robotic surgery industry was marked by two important announcements. On February 22, 2024, FDA granted 510(k) clearance to …
March 5, 2024
by Andrii Buvailo, PhD
News
Elsevier, a global provider of information and analytics in science and health with 140 years of history, has entered into …
March 4, 2024
by Andrii Buvailo
Biopharma insight
The biotech industry has been witnessing a paradigm shift in recent years as it moves away from traditional clinical trials …
March 4, 2024
by BiopharmaTrend
News
Lantern Pharma, a NASDAQ-listed company specializing in AI-driven cancer drug discovery and development, has announced a milestone with its artificial intelligence platform …
Feb. 29, 2024
by Andrii Buvailo, PhD
News
A new five-year commercial agreement and go-to-market collaboration aims to merge 1910 Genetics' comprehensive computational and biological data with Microsoft’s HPC …